Skip to main content
. 2016 Jun 18;15:87. doi: 10.1186/s12933-016-0409-2

Table 2.

Discontinuance criteria

Serum UA >12.0 mg/dL
Onset of gout arthritis
Considered inappropriate to continue the study by investigators due to adverse side effects or serious adverse events
Needed to receive any prohibited concomitant drugs
Participant relocated or changed doctor
The participant decides they no longer wish to continue the study
Considered inappropriate to continue the study by investigators due to some other reason

UA uric acid